Nycomed Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Zurich Switzerland (1996)
Status: Acquired by Hafslund (1986)

Organization Overview

First Clinical Trial
2002
NCT00592917
First Marketed Drug
2004
terconazole (terazol)
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Leiras-Nycomed | Nycomed Deutschland GmbH, 78467 Konstanz, Germany | Nycomed Germany GmbH | Nycomed GmbH | NYCOMED US | NYCOMED US INC | Nyegaard & Co